In Treatment

GRACE sat down with Dr. Marco Ruiz to discuss information regarding novel new drugs in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) and how they work (¿Fármacos nuevos para la leucemiamieloideaguda (LMA) y para el síndrome mielodisplásico (MDS) y ¿Cómofuncionan?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Acute Myeloid Leukemia & Myelodysplastic Syndrome, (Leucemia mieloide aguda y síndrome mielodisplásico).

Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses What is the role for PD-L1 testing after first line treatment for advanced NSCLC in initial diagnosis today.

GRACE sat down with Dr. Marco Ruiz to discuss information regarding when and who to refer for hematopoietic cell transplantation (HCT) (¿Cuándo y para quién se recomienda el trasplante de células hematopoyéticas (TCH)?).  Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Acute Myeloid Leukemia & Myelodysplastic Syndrome, (Leucemia mieloide aguda y síndrome mielodisplásico).

We would like to thank the following company for their support of this program:

GRACE sat down with Dr. Marco Ruiz to discuss information regarding acute myeloid leukemia (AML) in elderly patients (Leucemia aguda mieloide (LMA) en la población de tercera edad).  Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Acute Myeloid Leukemia & Myelodysplastic Syndrome (Leucemia mieloide aguda y síndrome mielodisplásico)

We would like to thank the following company for their support of this program:

GRACE sat down with Dr.

GRACE sat down with Dr. Marco Ruiz to discuss information regarding the role of surveillance imaging in indolent lymphomas and chronic lymphocytic leukemia (CLL) (¿Cuál es el rol de vigilancia imagenológica en linfomas indolentes y en la leucemia crónica linfocítica?).  Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Chronic Lymphocytic Leukemia & Non-Hodgkin Lymphoma, (Leucemia crónica linfocítica y linfoma no Hodgkin).

GRACE sat down with Dr. Marco Ruiz to discuss information regarding all diffuse large B-cell lymphoma (DLBCL) and are they made equally ("¿Todos los linfomas difusos de linfocitos B (DLBCL) están hechos iguales?"). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Chronic Lymphocytic Leukemia & Non-Hodgkin Lymphoma, (Leucemia crónica linfocítica y linfoma no Hodgkin).

We would like to thank the following company for their support of this program:

Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses Is There An Optimal Chemo Regimen For Squamous Non-Small Cell Lung Cancer (NSCLC).

GRACE sat down with Dr. Marco Ruiz to discuss "What are the risks and benefits of Ibrutinib and Idelalisib?" for our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments.